HK Stock MarketDetailed Quotes
00241 ALI HEALTH
- 3.470
- +0.060+1.76%
Trading Dec 23 09:49 CST
55.84BMarket Cap41.81P/E (TTM)
3.500High3.450Low3.95MVolume3.450Open3.410Pre Close13.70MTurnover0.03%Turnover Ratio56.89P/E (Static)16.09BShares6.30052wk High3.30P/B55.84BFloat Cap2.59052wk Low--Dividend TTM16.09BShs Float30.150Historical High--Dividend LFY1.47%Amplitude0.068Historical Low3.467Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
ALI HEALTH Key Stats
All
YOY
| (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 70.60%821.07M | 70.49%939.4M | 176.63%481.27M | 318.20%550.99M | 175.69%173.98M | -162.94%-252.51M | -170.85%-229.86M | 4,311.91%401.22M | 5,664.77%324.44M | 114.95%9.09M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -12.10%-229.03M | -44.16%-478.03M | -39.46%-204.31M | -58.02%-331.59M | -69.45%-146.5M | -26.86%-209.84M | -38.15%-86.46M | -194.28%-165.42M | -275.37%-62.58M | -124.34%-56.21M |
| Dividend (income)- adjustment | ---- | ---24.5M | ---- | ---- | ---- | -174.47%-3.74M | -175.13%-3.75M | 27.27%-1.36M | ---1.36M | ---1.87M |
| Investment loss (gain) | ---3.72M | -127.56%-6.03M | ---- | ---2.65M | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | 161.88%21.45M | 152.07%5.93M | 2,227.53%8.19M | -124.95%-11.38M | -101.58%-385K | 18.76%45.62M | -37.32%24.39M | 12.87%38.41M | 63.71%38.9M | 1,970.07%34.03M |
| Impairment and provisions: | 1,102.64%304.79M | -47.31%91.12M | -163.11%-30.4M | 247.14%172.93M | 90.41%48.17M | 30.40%49.82M | 1,844.35%25.3M | 115.89%38.2M | 150.25%1.3M | 259.31%17.7M |
| -Impairmen of inventory (reversal) | 465.82%102.37M | -44.56%88.48M | -158.57%-27.98M | 230.22%159.59M | 95.37%47.78M | 48.82%48.33M | 1,692.82%24.45M | 74.76%32.48M | 200.15%1.36M | 261.23%18.58M |
| -Impairment of trade receivables (reversal) | -44.71%47K | 181.96%5.14M | -78.26%85K | 1,281.82%1.82M | -53.56%391K | 141.25%132K | 1,436.51%842K | 63.96%-320K | 94.87%-63K | -172.43%-888K |
| -Other impairments and provisions | 8,194.92%202.37M | -121.71%-2.5M | ---2.5M | 748.78%11.52M | ---- | -77.56%1.36M | ---- | --6.05M | ---- | ---- |
| Revaluation surplus: | -163.79%-59.98M | 1,374.86%358.31M | 96.00%94.02M | 82.35%-28.11M | 121.41%47.97M | -188.08%-159.28M | -378.33%-224.1M | -351.28%-55.29M | -809.33%-46.85M | 183.83%22M |
| -Other fair value changes | -163.79%-59.98M | 1,374.86%358.31M | 96.00%94.02M | 82.35%-28.11M | 121.41%47.97M | -188.08%-159.28M | -378.33%-224.1M | -351.28%-55.29M | -809.33%-46.85M | 183.83%22M |
| Asset sale loss (gain): | 97.76%-1.49M | -3.97%-66.94M | -83,111.25%-66.41M | 83.12%-64.39M | 100.34%80K | -364.60%-381.53M | -173.34%-23.72M | -29.15%-82.12M | 77.64%-8.68M | -411.45%-63.58M |
| -Loss (gain) from sale of subsidiary company | 97.50%-1.66M | -3.24%-66.4M | ---66.4M | 83.14%-64.32M | ---- | -364.00%-381.39M | -173.10%-23.7M | -29.33%-82.2M | 77.64%-8.68M | -411.82%-63.55M |
| -Loss (gain) on sale of property, machinery and equipment | 4,225.00%173K | -709.23%-526K | -95.00%4K | 54.23%-65K | 480.95%80K | -289.33%-142K | ---21K | 341.94%75K | ---- | -106.67%-31K |
| -Loss (gain) from selling other assets | ---- | ---10K | ---10K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 4.72%26.42M | -15.75%53.68M | -29.73%25.23M | 5.19%63.72M | 55.67%35.9M | 52.87%60.58M | 31.51%23.06M | -4.95%39.63M | -7.16%17.53M | 945.10%41.69M |
| -Depreciation | 32.94%4.82M | -27.17%6.93M | -29.11%3.62M | -4.65%9.51M | 67.23%5.11M | 63.52%9.98M | 119.15%3.06M | 4.67%6.1M | -39.86%1.39M | 46.15%5.83M |
| -Amortization of intangible assets | -0.60%8.45M | -3.17%16.96M | -6.77%8.5M | 47.11%17.51M | 269.74%9.11M | 491.41%11.91M | 152.04%2.47M | 36.29%2.01M | -11.41%978K | --1.48M |
| Financial expense | -39.46%1.49M | 2.33%5.97M | -27.04%2.45M | 52.90%5.83M | 356.17%3.36M | 55.78%3.82M | -53.35%737K | -88.85%2.45M | -91.88%1.58M | -21.46%21.97M |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 298.38%3.55M | ---- |
| Special items | -20.04%124.31M | -14.78%266.79M | 1.13%155.46M | -23.27%313.07M | -15.95%153.73M | 2.84%408.02M | -9.54%182.9M | 43.17%396.77M | 37.40%202.2M | 29.81%277.14M |
| Operating profit before the change of operating capital | 115.96%1.01B | 71.40%1.15B | 47.18%465.51M | 252.24%668.44M | 201.53%316.29M | -171.68%-439.06M | -166.28%-311.52M | 102.85%612.49M | 190.80%470.03M | 170.85%301.95M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -183.52%-336.8M | 186.29%614.1M | 479.13%403.26M | -450.85%-711.69M | 66.22%-106.37M | 54.48%-129.2M | -1,135.51%-314.88M | 55.58%-283.83M | 108.28%30.41M | -351.65%-638.96M |
| Accounts receivable (increase)decrease | -107.55%-58.22M | -227.26%-211.49M | -60.29%-28.05M | 68.00%-64.63M | 90.87%-17.5M | -2,815.19%-201.98M | -16,852.79%-191.74M | -82.20%7.44M | -100.69%-1.13M | 116.12%41.8M |
| Accounts payable increase (decrease) | -16.88%-263.24M | -278.19%-491.43M | -176.39%-225.23M | -75.66%275.79M | -82.93%294.86M | 27.80%1.13B | 1,335.55%1.73B | -12.96%886.41M | -69.72%120.34M | 25.70%1.02B |
| prepayments (increase)decrease | -46.28%62.74M | 16.15%-180.16M | 191.58%116.8M | -29.76%-214.85M | 65.03%-127.53M | 51.57%-165.58M | -179.52%-364.7M | -125.09%-341.92M | -238.48%-130.47M | 16.25%-151.9M |
| Special items for working capital changes | 287.92%126.3M | ---- | 10.30%32.56M | ---- | 1,222.75%29.52M | 31.95%35.02M | -107.38%-2.63M | 192.50%26.54M | 109.80%35.61M | -171.73%-28.7M |
| Cash from business operations | -29.91%536.09M | 2,834.78%894.17M | 96.48%764.84M | -86.87%30.47M | -28.18%389.27M | -74.42%232.07M | 3.29%542.03M | 67.17%907.14M | 12.19%524.77M | 42.99%542.64M |
| Hong Kong profits tax paid | -100.17%-6K | 756.14%3.26M | --3.53M | 87.51%-497K | ---- | 3.56%-3.98M | ---2.21M | -215.44%-4.13M | ---- | -557.29%-1.31M |
| China income tax paid | 14.67%-23.9M | -2.95%-43.87M | -51.31%-28M | -3.04%-42.62M | 51.91%-18.51M | -73.98%-41.36M | -220.20%-38.49M | -228.92%-23.77M | -37.62%-12.02M | 53.09%-7.23M |
| Interest received - operating | -70.13%51.45M | -15.29%232.25M | 26.06%172.26M | 13.55%274.17M | 40.72%136.65M | 82.04%241.45M | 75.84%97.11M | 151.95%132.64M | 198.39%55.23M | 62.05%52.64M |
| Interest paid - operating | 39.46%-1.49M | -2.33%-5.97M | 27.04%-2.45M | -52.90%-5.83M | -356.17%-3.36M | -55.78%-3.82M | 53.35%-737K | 21.83%-2.45M | 17.15%-1.58M | ---3.13M |
| Net cash from operations | -38.24%562.16M | 322.32%1.08B | 80.57%910.18M | -39.75%255.69M | -15.67%504.05M | -57.96%424.36M | 5.53%597.7M | 72.96%1.01B | 19.08%566.4M | 47.24%583.62M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 607.77%173.04M | 90.57%84.97M | --24.45M | 25,526.44%44.59M | ---- | -85.28%174K | 21.28%1.38M | -47.84%1.18M | --1.14M | --2.27M |
| Dividend received - investment | -23.32%3.01M | 1,042.70%28.42M | 57.58%3.92M | -47.26%2.49M | -47.38%2.49M | 246.00%4.72M | 246.74%4.73M | -58.50%1.36M | --1.36M | --3.28M |
| Loan receivable (increase) decrease | ---- | --2.5M | --2.5M | ---- | ---- | -38.22%13.9M | -44.40%13.9M | 50.00%22.5M | --25M | --15M |
| Decrease in deposits (increase) | -11.13%-627.87M | -1,217.77%-4.96B | -19.01%-564.97M | -111.86%-376.77M | -121.83%-474.72M | 172.48%3.18B | 145.73%2.17B | ---4.38B | -2,146.46%-4.75B | ---- |
| Sale of fixed assets | 25.13%234K | 81.11%748K | --187K | -77.75%413K | ---- | 125.79%1.86M | 203.41%622K | 627.43%822K | --205K | 135.42%113K |
| Purchase of fixed assets | 81.12%-3.11M | -305.81%-22.77M | -246.98%-16.49M | 62.41%-5.61M | 29.88%-4.75M | 12.57%-14.93M | -367.45%-6.78M | -125.68%-17.08M | 49.53%-1.45M | -24.01%-7.57M |
| Purchase of intangible assets | ---1K | 98.05%-6K | ---- | -66.49%-308K | 57.14%-24K | 61.54%-185K | 88.73%-56K | 91.91%-481K | 91.62%-497K | ---5.94M |
| Sale of subsidiaries | ---- | 113.44%99.25M | --99.25M | --46.5M | ---- | ---- | ---- | -109.19%-10.61M | ---- | --115.41M |
| Acquisition of subsidiaries | ---- | -69.45%-131.03M | ---131.15M | ---77.33M | ---- | ---- | ---- | ---275.57M | ---10M | ---- |
| Recovery of cash from investments | --1.8B | --412.2M | ---- | ---- | ---- | --35.98M | -93.39%26.68M | ---- | -37.38%403.42M | ---- |
| Cash on investment | -417.76%-2.09B | -121.52%-403.66M | -121.52%-403.66M | 56.06%-182.22M | -38.36%-182.22M | -542.49%-414.7M | -115.50%-131.7M | 51.91%-64.55M | 47.99%-61.11M | 88.01%-134.21M |
| Other items in the investment business | 8.51%7.12M | -15.26%13.39M | 108.48%6.56M | 101.69%15.8M | 89.58%-77.33M | -297.56%-932.57M | ---742.07M | -117.29%-234.57M | ---- | 162.84%1.36B |
| Net cash from investment operations | 25.07%-733.87M | -816.71%-4.88B | -32.97%-979.41M | -128.44%-532.44M | -154.92%-736.55M | 137.74%1.87B | 130.50%1.34B | -468.78%-4.96B | -1,323.46%-4.4B | 156.16%1.35B |
| Net cash before financing | -148.03%-171.71M | -1,273.49%-3.8B | 70.22%-69.23M | -112.05%-276.75M | -111.99%-232.5M | 158.11%2.3B | 150.62%1.94B | -304.88%-3.95B | -558.69%-3.83B | 196.48%1.93B |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -181.38%-1.7B |
| Issuing shares | 98.83%340K | -93.19%878K | -97.91%171K | 32.98%12.89M | 32.02%8.19M | -99.89%9.69M | -99.93%6.2M | 325.73%8.99B | 345.32%8.98B | 3,887.55%2.11B |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -240.37%-36.16M |
| Issuance expenses and redemption of securities expenses | -68.75%-22.93M | -28.18%-104.57M | ---13.59M | -393.87%-81.58M | ---- | 58.26%-16.52M | ---- | -122.18%-39.58M | ---- | 52.93%-17.81M |
| Other items of the financing business | ---- | ---1.84B | ---- | ---- | ---- | -4,254.55%-4.79M | ---4.79M | ---110K | ---- | ---- |
| Adjustment item of financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---110K | ---- |
| Net cash from financing operations | -28.50%-38.69M | -1,681.48%-1.98B | -88.08%-30.11M | -89.80%-111.28M | 23.09%-16.01M | -100.66%-58.63M | -100.23%-20.82M | 2,613.51%8.92B | 606.25%8.96B | -80.75%328.81M |
| Effect of rate | -127.68%-50.7M | -87.02%36.78M | -40.90%183.17M | 290.37%283.45M | 350.11%309.91M | 52.44%-148.89M | 40.77%-123.91M | -651.20%-313.06M | -428.24%-209.21M | -9.57%56.8M |
| Other items affecting net cash | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --110K | ---- |
| Net Cash | -111.80%-210.4M | -1,390.49%-5.78B | 60.03%-99.34M | -117.34%-388.02M | -112.96%-248.51M | -54.97%2.24B | -62.59%1.92B | 120.14%4.97B | 143.79%5.13B | 876.28%2.26B |
| Begining period cash | -62.21%3.49B | -1.12%9.24B | -1.12%9.24B | 28.81%9.34B | 28.81%9.34B | 179.47%7.25B | 179.47%7.25B | 825.55%2.59B | 825.55%2.59B | -44.85%280.37M |
| Cash at the end | -65.36%3.23B | -62.21%3.49B | -0.87%9.32B | -1.12%9.24B | 3.94%9.4B | 28.81%9.34B | 20.40%9.05B | 179.47%7.25B | 207.00%7.51B | 825.55%2.59B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 396.42%6.95B | 1,150.27%2.03B |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 396.42%6.95B | 1,150.27%2.03B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
